NONE

Glioblastoma Multiforme

Recurrent Glioblastoma Multiforme

MDA 2004-0062: Prior Radiation Therapy within 5 weeks required. Temozolomide (TMZ) versus TMZ plus Thalidomide versus TMZ plus Celecoxib versus TMZ plus Thalidomide plus Isotretinoin versus TMZ plus Thalidomide plus Celecoxib versus TMZ plus Isotretinoin plus Celecoxib versus TMZ plus Thalidomide plus Celecoxib

RTOG 0513: Temozolomide, Motexafin Gadolinium and Radiation Therapy

RTOG 0627: Dasatinib (Suspended 10/07)

RTOG 0625: Bevacizumab with irinotecan versus temozolomide

ECOG E1F05: Rituximab in conjunction with standard chemotherapy

RTOG 0227: Pre-irradiation Chemotherapy (Methotrexate / Rituximab / Temozolomide) and Post Irradiation Temozolomide

Primary NonSmall Cell Lung Cancer Brain Metastases

RTOG 0320: (1 to 3 lesions) Whole Brain and Stereotactic Radiation Therapy versus Whole Brain and Stereotactic Radiation Therapy, Temozolomide or Gefitinib

Grade II Astrocytoma Oligoastrocytoma Oligodendroglioma